153 related articles for article (PubMed ID: 1285443)
1. The utility of CD20 and CD43 in subclassification of low-grade B-cell lymphoma on paraffin sections.
Contos MJ; Kornstein MJ; Innes DJ; Ben-Ezra J
Mod Pathol; 1992 Nov; 5(6):631-3. PubMed ID: 1285443
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin's lymphomas of small lymphocytes.
de Leon ED; Alkan S; Huang JC; Hsi ED
Mod Pathol; 1998 Nov; 11(11):1046-51. PubMed ID: 9831200
[TBL] [Abstract][Full Text] [Related]
3. CD43 expression in B cell lymphoma.
Treasure J; Lane A; Jones DB; Wright DH
J Clin Pathol; 1992 Nov; 45(11):1018-22. PubMed ID: 1280654
[TBL] [Abstract][Full Text] [Related]
4. Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel.
Chen CC; Raikow RB; Sonmez-Alpan E; Swerdlow SH
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):1-11. PubMed ID: 10937042
[TBL] [Abstract][Full Text] [Related]
5. Frequency of CD43 expression in non-Hodgkin lymphoma. A survey of 742 cases and further characterization of rare CD43+ follicular lymphomas.
Lai R; Weiss LM; Chang KL; Arber DA
Am J Clin Pathol; 1999 Apr; 111(4):488-94. PubMed ID: 10191768
[TBL] [Abstract][Full Text] [Related]
6. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
Matolcsy A; Chadburn A; Knowles DM
Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
[TBL] [Abstract][Full Text] [Related]
7. Detection of immunophenotypic abnormalities in paraffin-embedded B-lineage non-Hodgkin's lymphomas.
Gelb AB; Rouse RV; Dorfman RF; Warnke RA
Am J Clin Pathol; 1994 Dec; 102(6):825-34. PubMed ID: 7801900
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
[TBL] [Abstract][Full Text] [Related]
9. Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features.
Zukerberg LR; Medeiros LJ; Ferry JA; Harris NL
Am J Clin Pathol; 1993 Oct; 100(4):373-85. PubMed ID: 8213632
[TBL] [Abstract][Full Text] [Related]
10. Value of immunohistochemistry in the diagnosis of leukemia cutis: study of 54 cases using paraffin-section markers.
Ratnam KV; Su WP; Ziesmer SC; Li CY
J Cutan Pathol; 1992 Jun; 19(3):193-200. PubMed ID: 1383298
[TBL] [Abstract][Full Text] [Related]
11. [CD43 in B-cell chronic lymphocytic leukemia].
Roliński J; Rupniewska ZM; Dmoszyńska A; Wasik-Szczepanek E; Bojarska-Junak A
Pol Arch Med Wewn; 1999 Sep; 102(3):753-62. PubMed ID: 10949882
[TBL] [Abstract][Full Text] [Related]
12. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
[TBL] [Abstract][Full Text] [Related]
13. CD5 expression in B-cell small lymphocytic malignancies. Correlations with clinical presentation and sites of disease.
Sundeen JT; Longo DL; Jaffe ES
Am J Surg Pathol; 1992 Feb; 16(2):130-7. PubMed ID: 1370753
[TBL] [Abstract][Full Text] [Related]
14. CD43 and CD5 antibodies define four normal and neoplastic B-cell subsets: a three-color flow cytometric study.
Lynch EF; Jones PA; Swerdlow SH
Cytometry; 1995 Sep; 22(3):223-31. PubMed ID: 8556954
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections.
Dorfman DM; Shahsafaei A
Mod Pathol; 1997 Sep; 10(9):859-63. PubMed ID: 9310947
[TBL] [Abstract][Full Text] [Related]
16. Antibody NCL-CD5 fails to detect neoplastic CD5+ cells in paraffin sections.
Ben-Ezra JM; Kornstein MJ
Am J Clin Pathol; 1996 Sep; 106(3):370-3. PubMed ID: 8816596
[TBL] [Abstract][Full Text] [Related]
17. Reliable and cost-effective paraffin section immunohistology of lymphoproliferative disorders.
Segal GH; Stoler MH; Fishleder AJ; Tubbs RR
Am J Surg Pathol; 1991 Nov; 15(11):1034-41. PubMed ID: 1928555
[TBL] [Abstract][Full Text] [Related]
18. A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.
Li Y; Tong X; Huang L; Li L; Wang C; He C; Liu S; Wang Z; Xiao M; Mao X; Zhang D
Cancer Med; 2021 Jul; 10(13):4387-4396. PubMed ID: 34061467
[TBL] [Abstract][Full Text] [Related]
19. Large cell lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. A flow cytometric analysis of seven cases.
Kroft SH; Dawson DB; McKenna RW
Am J Clin Pathol; 2001 Mar; 115(3):385-95. PubMed ID: 11242795
[TBL] [Abstract][Full Text] [Related]
20. B-zone small lymphocytic lymphoma: a morphologic, immunophenotypic, and clinical study with comparison to "well-differentiated" lymphocytic disorders.
Carbone A; Pinto A; Gloghini A; Volpe R; Zagonel V
Hum Pathol; 1992 Apr; 23(4):438-48. PubMed ID: 1563746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
